Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Estimating the rate of accumulating drug resistance mutations in the HIV genome.

Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research - 1 Jan 2000

Braithwaite R Scott, Shechter Steven, Chang Chung-Chou H, Schaefer Andrew, Roberts Mark S

Abstract excerpt

OBJECTIVE: HIV mutation accumulation has great implications for pharmacoeconomics and clinical care, yet scarcity of data has hindered its representation in decision analytic models. Our objective is to determine the accuracy with which mutation accumulation and other unmeasured parameters could be estimated during model calibration. METHODS: We used a second-order Monte Carlo simulation of HIV natural history...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antiretroviral Therapy, Highly Active
Share to Calibration

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Computer Simulation

Share to Drug Resistance, Viral

Share to Monte Carlo Method

Share to Patient Compliance

Share to Reproducibility of Results

Source

Identifiers

PMID: 17532813
DOI: 10.1111/j.1524-4733.2007.00170.x

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Estimating the rate of accumulating drug resistance mutations in the HIV genome.PMID 17532813Read ↗

Explaining variability in the relationship between antiretroviral adherence and HIV mutation accumulation.Semantic proximity Read ↗

Effectiveness and cost-effectiveness of potential responses to future high levels of transmitted HIV drug resistance in antiretroviral drug-naive populations beginning treatment: modelling study and economic analysisSemantic proximity Read ↗

Modeling the HIV Protease Inhibitor Adherence–Resistance Curve by Use of Empirically Derived EstimatesSemantic proximity Read ↗

Combining cross-sectional and prospective data methods to improve transition parameter estimation for characterizing the accumulation of HIV-1 drug resistance mutations.Semantic proximity Read ↗

Joint modeling of progression of HIV resistance mutations measured with uncertainty and failure time data.Semantic proximity Read ↗

Projecting the Benefits of Antiretroviral Therapy for HIV Prevention: The Impact of Population Mobility and Linkage to CareSemantic proximity Read ↗

Real-time predictions of reservoir size and rebound time during antiretroviral therapy interruption trials for HIVSemantic proximity Read ↗

Influence of alternative thresholds for initiating HIV treatment on quality-adjusted life expectancy: a decision model.Semantic proximity Read ↗

The long-term benefits of genotypic resistance testing in patients with extensive prior antiretroviral therapy: a model-based approach.Semantic proximity Read ↗

Modeling HIV dynamics and antiviral response with consideration of time-varying drug exposures, adherence and phenotypic sensitivity.Semantic proximity Read ↗

Markov models for accumulating mutationsSemantic proximity Read ↗

Accommodating uncertainty in a tree set for function estimation.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.